comparemela.com
Home
Live Updates
Dk Novo B - Breaking News
Pages:
2
3
4
5
6
7
8
Dk Novo B News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Viking Therapeutics stock soars 61% premarket after company reports positive results in trial of weight-loss drug
Viking posted positive results from a mid-stage trial of its GLP-1 drug.
Drug administration
Therapeutics inc
Viking therapeutics
Article normal
Agricultural machinery
Health care
Specialized drugs medications
Hormone products
Industrial goods
Diabetes drugs
Regulation government policy
Financial performance
Share price movement disruptions
New products services
Research development
Corporate industrial news
Viking Therapeutics stock doubles as investors cheer cheap entry to weight-loss drug craze
Viking posted positive results from a mid-stage trial of its GLP-1 drug.
Therapeutics inc
Viking therapeutics
Article normal
Agricultural machinery
Health care
Specialized drugs medications
Hormone products
Industrial goods
Diabetes drugs
Regulation government policy
Financial performance
Share price movement disruptions
New products services
Research development
Corporate industrial news
Products services
Viking Therapeutics stock benefits as investors cheer weight-loss-drug results
Viking posted positive results from a mid-stage trial of its GLP-1 drug.
Therapeutics inc
Viking therapeutics
Article normal
Agricultural machinery
Health care
Specialized drugs medications
Hormone products
Industrial goods
Diabetes drugs
Regulation government policy
Financial performance
Share price movement disruptions
New products services
Research development
Corporate industrial news
Products services
Coca-Cola Meets Earnings Estimates and Beats on Sales Higher Prices Help
Coca-Cola posts fourth-quarter adjusted earnings of 49 cents a share, matching estimates.
United states
James quincey
Justin sullivan getty
Evie liu
Novo nordisk ozempic
Federal reserve
Coca cola
Getty images
North america
Wall street
Latin america
Latin american
Novo nordisk
Article normal
Food beverages
Soft drinks
Liver Disease Biotechs Stocks Crash on Eli Lilly s Mounjaro Data
New clinical trial results from El Lilly suggest its Type 2 diabetes and weight-loss drug, tirzepatide, could upend the incipient market for MASH treatments.
United states
Eli lilly
George frey bloomberg
Andy hsieh
Josh nathan kazis
Raymond james
Eli lilly mounjaro
William blair
Steven seedhouse
Daniel skovronsky
Intercept pharmaceuticals
Madrigal pharmaceuticals
Drug administration
Novo nordisk
Akero therapeutics
Viking therapeutics
vimarsana © 2020. All Rights Reserved.